NAURA Technology Group (002371) Report Interpretation
Q2 revenue missed UBS expectations on timing, while net profit was in line. UBS argues that order-recognition timing, better expense control and wider high-end tool adoption leave its full-year growth case intact.
Summary
Q2 revenue missed UBS expectations on timing, while net profit was in line. UBS argues that order-recognition timing, better expense control and wider high-end tool adoption leave its full-year growth case intact.
- Q2 revenue rose 24% year on year but fell 4.7% sequentially and was 9% below UBS expectations.
- Q2 attributable net profit was Rmb1.735bn, up 6.6% year on year and 6.2% sequentially, in line with expectations.
- UBS forecasts 2026 revenue growth of 32% year on year.
- Q2 blended gross margin fell 1.5 percentage points sequentially to 39.3%, but EBIT margin and recurring net margin improved sequentially.
- UBS highlights customer validation, batch deliveries and scaled supply across advanced etching, deposition, packaging and ion-implantation tools.
Report Interpretation
Overview
This UBS update reviews NAURA’s Q2 2026 results and its progress in high-end semiconductor equipment. UBS maintains Buy and an Rmb800.00 target, viewing the revenue shortfall as a timing issue rather than a change in the full-year growth outlook.
Core views
NAURA reported Q2 revenue of Rmb? not stated in the report body, up 24% year on year but down 4.7% sequentially and 9% below UBS expectations. UBS attributes the sequential decline mainly to the timing of order revenue recognition, rather than weaker underlying demand. The comparison with domestic peers also reflects a higher base: NAURA’s Q1 revenue performance was stronger than peers, with a 14% sequential decline versus an average 32% decline for AMEC, ACM and Piotech, while those peers averaged 48% sequential revenue growth in Q2. Because domestic semiconductor-equipment revenue recognition generally runs on a roughly 12-month cycle, UBS believes the Q2 timing effect should have limited impact on the full-year outlook. It forecasts 2026 revenue growth of 32% year on year and cites industry checks and improving downstream demand as supporting evidence. Q2 attributable net profit was Rmb1.735bn, up 6.6% year on year and 6.2% sequentially, and was in line with UBS expectations. Blended gross margin declined 1.5 percentage points sequentially to 39.3%, which UBS attributes to product-mix changes and commercial discounts for some major customers. However, EBIT margin and recurring net profit margin improved by 1.0 and 1.8 percentage points sequentially, respectively, helped by tighter expense control. UBS also estimates that semiconductor-equipment gross margin remained above that of most domestic peers, noting that the segment’s margin is generally much higher than NAURA’s electronic industrial equipment margin. The report’s longer-term operating case rests on wider coverage of high-end equipment and customer-side progress. NAURA expanded shipments in etching, thin-film deposition and thermal processing, while penetration advanced in advanced logic, advanced memory and power semiconductors. In the first half, its high-end ICP etching tool, with angstrom-level uniformity and an aspect ratio of several hundred to one, completed customer validation and was being introduced into mass production for advanced logic and high-end memory applications. Its new-generation tube-type ALD tool was delivered in batches to domestic memory manufacturers; high-end TSV electroplating achieved scaled supply for advanced packaging and 3D integration; and ion-implantation orders and deliveries increased steadily. UBS maintains a 12-month Buy rating and Rmb800.00 price target. The target is based on 50x 2027E P/E and implies 1.4x PEG using a 35% 2027-29E EPS CAGR. At Rmb700.40 on 25 August 2026, UBS presents forecast price appreciation of 14.2%, dividend yield of 0.1%, and forecast stock return of 14.4%, compared with a 6.8% market-return assumption and 7.6% forecast excess return. UBS forecasts revenue of Rmb51.830bn and diluted EPS of Rmb9.36 for 2026E, rising to Rmb72.480bn and Rmb16.00 in 2027E, and Rmb95.551bn and Rmb23.07 in 2028E.
Analysis framework
UBS compares the quarter with its own expectations, prior-quarter performance and domestic peers, then assesses whether revenue timing changes the full-year outlook. It combines margin analysis, industry checks, product-launch and customer-validation progress, earnings forecasts and a forward P/E valuation to support its rating and target price.
Methodology notes
Forward P/E valuation cross-checked with PEG
UBS sets the Rmb800.00 target using 50x 2027E P/E; the resulting valuation implies 1.4x PEG based on a 35% 2027-29E EPS CAGR.
Revenue-recognition timing analysis
UBS interprets the Q2 revenue miss through the timing of equipment order recognition and compares sequential revenue trends with peers to judge the full-year demand outlook.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- NAURA Technology Group (002371.SZ)Primary covered company; UBS expects high-end equipment expansion and improving downstream demand to support growth.
- Strengths
- Expanded shipments across etching, deposition and thermal processing; customer validation and supply progress in advanced equipment; improving operating profitability through expense control.
- Weaknesses
- Q2 revenue was below UBS expectations and blended gross margin declined sequentially.
- Comparison
- Q2 sequential revenue growth of -4.7% lagged the +48% average for AMEC, ACM and Piotech, though UBS attributes part of this to NAURA’s stronger Q1 base.
- Risks
- Geopolitical restrictions, weaker China WFE demand and stronger competition in etching, deposition and cleaning could pressure share and results.
Key data
- Q2 revenue growth+24% YoY / -4.7% QoQRevenue was 9% below UBS expectations; UBS attributes this mainly to order-recognition timing.
- Q2 attributable net profitRmb1.735bn+6.6% YoY and +6.2% QoQ; in line with UBS expectations.
- Q2 blended gross margin39.3%Down 1.5 percentage points sequentially, reflecting mix changes and customer discounts.
- 2026E revenue growth+32% YoYUBS forecast; full-year visibility is viewed as intact.
- 2027E EPS CAGR35% for 2027-29EUsed in the PEG implication of the target valuation.
- Target valuation50x 2027E P/ESupports the Rmb800.00 price target.
Impact & implications
UBS views the Q2 revenue miss as a recognition-timing issue, while in-line profit, sequential margin improvement and progress in advanced tools support its view that NAURA can sustain full-year growth and broaden its high-end semiconductor-equipment presence.
Risks
- Geopolitical tensions could intensify and restrictions could be extended.
- China WFE demand could be weaker than UBS expects.
- Competition could intensify, causing market-share losses in etching, deposition and cleaning.
What to watch
- Whether China memory-fab capital expenditure rises further.
- Whether overseas peers raise product prices, improving the domestic pricing and profitability environment.
- Progress in winning overseas fab customers.
- Further market-share gains in China and technology breakthroughs in etching and deposition.